The multi-programme partnership will also see Relation applying its platform to a range of fibrotic conditions as well as ...

GSK has handed over $45 million upfront to fellow London-based firm Relation to help the pharma identify new targets for ...

Big pharma company GSK and UK AI-biotech Relation Therapeutics have entered into two strategic collaborations to identify and ...

FOR IMMEDIATE RELEASERelation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and ...

As part of the deal, GSK will pay Relation $45 million in upfront payments, which includes an equity investment of $15 million.

Relation announced two multi-program strategic collaborations with GSK (GSK). The collaborations will focus on the identification and ...

Machine learning and AI have sparked a transformation in drug discovery, but cracking the biology is still paramount. That's ...

Relation Therapeutics and GSK signed two contracts to discover and develop new therapeutic targets to treat osteoarthritis and fibrotic disease.

Relation Therapeutics Ltd. has delivered the first commercial validation of its combined wet lab/in silico platform for homing in on disease-related genes in the thick of the genome, signing two ...

UK-based biotech Relation Therapeutics today announced two multi-program strategic collaborations with pharma major GSK. The ...